Evidence map›Paper›PMID 31824436›Full record

ArticleFrontiers in microbiology2019

Phenotypic and Molecular Epidemiology of ESBL-, AmpC-, and Carbapenemase-Producing

Epp Sepp, Reidar Andreson, Arta Balode, Anastasia Bilozor, Age Brauer, Svetlana Egorova, Kristi Huik, Marina Ivanova, Lidia Kaftyreva, Siiri Kõljalg and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Collection of human bacteria at University of Tartu, Estonia.Microbiology resource announcements · 2026
    Article
  3. Genomic epidemiology of third-generation cephalosporin-resistantOne health (Amsterdam, Netherlands) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Extended-spectrum beta-lactamase inOne health (Amsterdam, Netherlands) · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Antibiotic resistance and ESBL production inBulletin of the National Research Centre · 2021
    Article
  18. Dissemination ofFrontiers in microbiology · 2021
    Article
  19. Hemolysin-Producing Strains among DiarrheagenicPathogens (Basel, Switzerland) · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 4 countries.

Epp SeppDepartment of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Reidar AndresonDepartment of Bioinformatics, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.
Arta BalodeDepartment of Biology and Microbiology, Rīga Stradiņš University, Riga, Latvia.
Anastasia BilozorDepartment of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Age BrauerDepartment of Bioinformatics, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.
Svetlana EgorovaDepartment of Enteric Infections, St. Petersburg Pasteur Institute, Saint Petersburg, Russia.
Kristi HuikDepartment of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Marina IvanovaDepartment of Microbiology, Central Laboratory, East-Tallinn Central Hospital, Tallinn, Estonia.
Lidia KaftyrevaDepartment of Enteric Infections, St. Petersburg Pasteur Institute, Saint Petersburg, Russia.
Siiri KõljalgDepartment of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Triinu KõressaarDepartment of Bioinformatics, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.
Maria MakarovaDepartment of Enteric Infections, St. Petersburg Pasteur Institute, Saint Petersburg, Russia.
Jolanta MiciulevicieneDepartment of Microbiology, Vilnius City Clinical Hospital, Vilnius, Lithuania.
Kristiine PaiDepartment of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Maido RemmDepartment of Bioinformatics, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.
Tiiu RööpDepartment of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Paul NaaberDepartment of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
University of Tartu · EESaint Petersburg Pasteur Institute · RUEast Tallinn Central Hospital · EENational Institutes of Health · USRiga Stradiņš University · LV

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extended-spectrum beta-lactamases (ESBL) and AmpC producing-

Indexed as

ESBL/AmpC/Carbapenemase genes epidemiologyEscherichia colimultilocus sequence typingNorthern and Eastern Europewhole genome sequencing

Identifiers

PMID31824436
PMCPMC6882919
OpenAlexW2981994671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.